|
专家访谈
|
医学的飞速发展已将人们的视线从“治病”逐渐转移至“防病”，因此ESC 2008年会上有关心血管风险预防的两场专题报告备受关注。尽管已有百年历史的阿司匹林其预防心血管事件作用显著，仍有众多患者并未充分应用，其原因何在？除抗血小板外关于阿司匹林有何新的基础....
|
TRANSCEND研究是ONTARGET的平行研究，旨在观察对ACEI不耐受的患者中替米沙坦的心血管保护作用，这是全球第一个ARB与安慰剂对照的大型里程碑式临床研究。其研究结果于德国当地时间2008年8月31日在德国慕尼黑召开的2008ESC公布，作为ONTAR....
|
International Circulation： Okay. Thank you very much Professor Peter Steg. I…representing the International Circulation…appreciate your ....
|
International Circulation：The accurate assessment of the haemodynamic severity of stenosis is crucial for clinical decision making in patients with ao....
|
International Circulation：As the coordinator of the interventional cardiology program of the annual meeting of the European society of cardiology， you....
|
International Circulation： Although most of clinical trials demonstrated drug-eluting stents (DES) is safe for CAD patients， we still focus on th....
|
International Circulation: The ASCOT-LLA trial demonstrated the significant benefits of adding atorvastatin to hypertension treatment in adults with t....
|
International Circulation: First of all， Professor Volpe， I would like to thank you very much for accepting this interview today with International Ci....
|
With the progression of CT technology， CT coronary angiography (CTCA) is frequently used as a noninvasive diagnostic tool for CHD. But the high radiat....
|
<International Circulation>: I’m here with Professor Antonio Colombo and also Professor Li Weimin. First of all I’d like to th....
|